TLP Group’s Allergan plc AGN Stock Holding History

TLP Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-261	Closed	-$50K	–	435
2018 Q3	$50K	Buy	+261	New	+$47.9K	0.08%	155

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

TLP Group's AGN Position: Q4 2018 in Review

TLP Group sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 261 shares — an estimated $50K sold.

TLP Group first reported a position in AGN in Q3 2018 and held it in 1 quarter. The position peaked at $50K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

TLP Group reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
TLP Group sold 261 Allergan plc shares in Q4 2018, an estimated $50K.
TLP Group first reported a position in Allergan plc in Q3 2018 and held it in 1 quarter.
TLP Group's Allergan plc position peaked at $50K in Q3 2018.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.